RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Rajesh Jha to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications Rajesh Jha has written about Xenograft Model Antitumor Assays.
Rajesh Jha
Connection Strength
0.035
Xenograft Model Antitumor Assays
  1. Agrawal S, Dwivedi M, Ahmad H, Chadchan SB, Arya A, Sikandar R, Kaushik S, Mitra K, Jha RK, Dwivedi AK. CD44 targeting hyaluronic acid coated lapatinib nanocrystals foster the efficacy against triple-negative breast cancer. Nanomedicine. 2018 02; 14(2):327-337.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support